Last updated on June 2019

Study of GEN-1 With NACT for Treatment of Ovarian Cancer (OVATION 2)


Brief description of study

This is a randomized, open label, multicenter trial to evaluate the safety, dosing, efficacy and biological activity of intraperitoneal GEN-1 plus NACT compared to NACT alone.

Clinical Study Identifier: NCT03393884

Find a site near you

Start Over

Innovative Clinical Research

Whittier, CA United States
6.57miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.